Prot# SP921: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 5-Arm, Parallel-Group Trial to Assess Rotigotine Transdermal System Dose Response in Subjects with Advanced-Stage Parkinson's Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date10/18/07 → 10/18/10

Funding

  • Schwarz BioSciences Inc. (SP921)